• 1. Essential effect of the electrolyte on the mechanical and chemical degradation of LiNi0.8Co0.15Al0.05O2 cathodes upon long-term cycling??
  Xiaoming Liu,Zachary D. Hood,Wangda Li,Donovan N. Leonard,Arumugam Manthiram,Miaofang Chi J. Mater. Chem. A, 2021,9, 2111-2119
• 2. Evolution of dealloying induced strain in nanoporous gold crystals?
  Ross Harder,David C. Dunand,Ian McNulty Nanoscale, 2017,9, 5686-5693
• 3. Evolution of calcium phosphate precipitation in hanging drop vapor diffusion by in situRaman microspectroscopy
  Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212
• 4. Dissociative electron attachment to HGaF4 Lewis–Br?nsted superacid
  Marcin Czapla,Jack Simons Phys. Chem. Chem. Phys., 2018,20, 21739-21745
• 5. Excimer and exciplex formation in a pair of bright phosphorescent isomers constructed from Cu3(pyrazolate)3 and Cu3I3 coordination luminophores?
  Shun-Ze Zhan,Mian Li,Xiao-Ping Zhou,Dan Li,Seik Weng Ng RSC Adv., 2011,1, 1457-1459

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Benzothiazoles Benzothiazoles
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Benzothiazoles

Introduction to 7-(trifluoromethyl)benzo[d]thiazol-2-amine (CAS No. 60388-39-8)

7-(trifluoromethyl)benzo[d]thiazol-2-amine, also known by its CAS number 60388-39-8, is a versatile compound with significant applications in the fields of medicinal chemistry and pharmaceutical research. This compound is characterized by its unique chemical structure, which includes a benzo[d]thiazole core and a trifluoromethyl group, making it an intriguing candidate for various biological and therapeutic studies.

The chemical structure of 7-(trifluoromethyl)benzo[d]thiazol-2-amine consists of a benzene ring fused to a thiazole ring, with a trifluoromethyl group attached to the 7-position of the benzene ring and an amino group at the 2-position of the thiazole ring. This arrangement confers specific electronic and steric properties that are crucial for its biological activity and potential therapeutic applications.

Recent research has highlighted the potential of 7-(trifluoromethyl)benzo[d]thiazol-2-amine in various biological systems. Studies have shown that this compound exhibits significant activity as an inhibitor of specific enzymes and receptors, making it a valuable tool in drug discovery and development. For instance, it has been investigated for its ability to modulate serotonin receptors, which are implicated in a range of neurological disorders such as depression and anxiety.

In addition to its potential as a serotonin receptor modulator, 7-(trifluoromethyl)benzo[d]thiazol-2-amine has also been explored for its anti-inflammatory properties. Research has demonstrated that this compound can effectively reduce inflammation in vitro and in vivo, suggesting its potential use in treating inflammatory diseases such as arthritis and inflammatory bowel disease.

The pharmacokinetic properties of 7-(trifluoromethyl)benzo[d]thiazol-2-amine have also been studied extensively. Its high lipophilicity allows it to cross biological membranes easily, which is beneficial for achieving therapeutic concentrations at target sites. However, this property also necessitates careful consideration of dosing and administration strategies to minimize potential side effects.

Clinical trials involving 7-(trifluoromethyl)benzo[d]thiazol-2-amine are currently underway to evaluate its safety and efficacy in human subjects. Preliminary results have been promising, with the compound showing good tolerability and a favorable safety profile. These findings have spurred further interest in developing this compound into a viable therapeutic agent.

Beyond its direct therapeutic applications, 7-(trifluoromethyl)benzo[d]thiazol-2-amine serves as an important scaffold for the design and synthesis of novel compounds with enhanced biological activities. Chemists and pharmacologists are actively exploring structural modifications to optimize its pharmacological properties, such as improving potency, selectivity, and metabolic stability.

In conclusion, 7-(trifluoromethyl)benzo[d]thiazol-2-amine (CAS No. 60388-39-8) is a promising compound with a wide range of potential applications in medicinal chemistry and pharmaceutical research. Its unique chemical structure and favorable biological properties make it an attractive candidate for further investigation and development into effective therapeutic agents.

• 73351-87-8(5,7-dimethyl-1,3-benzothiazol-2-amine)
• 791595-76-1(N-methyl-6-(trifluoromethyl)-1,3-benzothiazol-2-amine)
• 14779-18-1(7-methyl-1,3-benzothiazol-2-amine)
• 777-12-8(6-(Trifluoromethyl)benzo[d]thiazol-2-amine)
• 80945-79-5(2-Hydrazinyl-5-(trifluoromethyl)-1,3-benzothiazole)
• 791595-78-3(5-Benzothiazolecarbonitrile, 2-amino-6-(trifluoromethyl)-)
• 60388-36-5(4-(Trifluoromethyl)benzo[d]thiazol-2-amine)
• 60388-38-7(5-(Trifluoromethyl)benzo[d]thiazol-2-amine)
• 791595-79-4(7-Benzothiazolecarbonitrile, 2-amino-6-(trifluoromethyl)-)
• 791595-80-7(2-Benzothiazolamine, 4-methyl-6-(trifluoromethyl)-)